Erasca, Inc.

As of October 31, 2025, Erasca, Inc. shows a bullish technical trend, supported by a bullish weekly MACD and moving averages, though mixed signals in monthly indicators and underperformance against the S&P 500 suggest caution.

As of October 31, 2025, Erasca, Inc. shows a bullish technical trend with positive momentum indicators, although caution is advised due to some mixed signals in longer-term metrics.

As of October 31, 2025, Erasca, Inc. shows a bullish technical trend supported by positive weekly indicators, despite a bearish monthly KST and mild bearish signals from Dow Theory.

As of October 3, 2025, Erasca, Inc. shows a bullish technical trend supported by positive weekly and monthly MACD signals, though mixed performance indicators suggest caution, with recent outperformance against the S&P 500 contrasted by negative year-to-date returns.

As of October 3, 2025, Erasca, Inc. shows a bullish technical trend supported by positive momentum indicators, despite some caution from the monthly KST, with strong recent performance outpacing the S&P 500, although year-to-date returns remain negative.

As of October 3, 2025, Erasca, Inc. shows a bullish technical trend with strong weekly performance, despite mixed signals from various indicators and underperformance over the longer term.

As of September 12, 2025, Erasca, Inc. shows a neutral technical trend with mixed indicators, mildly bullish weekly and monthly MACD, and has outperformed the S&P 500 recently, but underperformed year-to-date and over the past year.

As of June 11, 2025, Erasca, Inc. shows a mildly bearish trend due to daily moving averages, despite some mixed signals from weekly indicators, suggesting caution in the current market outlook.

Erasca, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $31 million and a market cap of $386.69 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -33.82%.

As of Jun 18, Erasca, Inc. has a market capitalization of 386.69 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -157.60 million over the latest four quarters. As of Dec'24, the company reported shareholder's funds of 423.50 million and total assets of 502.53 million.